Used in pharmaceutical research as a key intermediate for developing central nervous system (CNS) agents, particularly in the synthesis of compounds targeting neurological disorders such as anxiety, depression, and epilepsy. Its structure supports binding to specific neurotransmitter receptors, making it valuable in optimizing drug candidates for improved efficacy and selectivity. Also explored in the development of novel analgesics due to its ability to modulate pain pathways with low off-target effects. Currently under investigation in preclinical studies for potential use in neurodegenerative disease therapy.